ANTI-HDV-IGM TESTING IN HEPATITIS DELTA REVISITED: CORRELATIONS WITH DISEASE ACTIVITY AND RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENT
dc.contributor.author | Mederacke, I. | |
dc.contributor.author | Yurdaydin, C. | |
dc.contributor.author | Bremer, B. | |
dc.contributor.author | Cakaloglu, Y. | |
dc.contributor.author | Erhardt, A. | |
dc.contributor.author | Yalcin, K. | |
dc.contributor.author | Zachou, K. | |
dc.date.accessioned | 2024-04-24T16:18:48Z | |
dc.date.available | 2024-04-24T16:18:48Z | |
dc.date.issued | 2010 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description | 45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver -- APR 14-18, 2010 -- Vienna, AUSTRIA | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | European Assoc Study Liver | en_US |
dc.identifier.doi | 10.1016/S0168-8278(10)60323-6 | |
dc.identifier.endpage | S135 | en_US |
dc.identifier.issn | 0168-8278 | |
dc.identifier.startpage | S135 | en_US |
dc.identifier.uri | https://doi.org/10.1016/S0168-8278(10)60323-6 | |
dc.identifier.uri | https://hdl.handle.net/11468/16286 | |
dc.identifier.volume | 52 | en_US |
dc.identifier.wos | WOS:000277018000322 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Bv | en_US |
dc.relation.ispartof | Journal of Hepatology | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keyword] | en_US |
dc.title | ANTI-HDV-IGM TESTING IN HEPATITIS DELTA REVISITED: CORRELATIONS WITH DISEASE ACTIVITY AND RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENT | en_US |
dc.title | ANTI-HDV-IGM TESTING IN HEPATITIS DELTA REVISITED: CORRELATIONS WITH DISEASE ACTIVITY AND RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENT | |
dc.type | Conference Object | en_US |